One-third of colorectal cancers diagnosed before 35 are hereditary, study finds
the ONA take:
Colorectal cancer is the third most common cancer in the United States, with the great majority of cases, approximately 90%, being diagnosed in individuals older than 50 years.
The odds of being diagnosed with CRC during one's lifetime is roughly five percent. Only 1.5 of CRC cases are diagnosed in individuals 35-years-old or younger.
Approximately 5% of all colorectal cases are due to hereditary causes, such as familial adenomatous polyposis (FAP) or Lynch syndrome. The prevalence of hereditary causes for CRC in younger people has not been examined in detail.
In this study, researchers from The University of Texas MD Anderson Cancer Center, led by Eduardo Vilar-Sanchez, M.D., Ph.D, assistant professor, Clinical Cancer Prevention, examined data from 193 patients that were diagnosed with CRC at or before age 35.
The investigators found that 35% of the younger CRC patients reviewed had a genetic origin to their disease, much higher than the overall CRC average.
The researchers advise, based on their results, that all patients diagnosed with CRC at age 35 or younger should receive a genetic evaluation, to better share the genetic risk information with family members.
Those with FAP stand a 100% chance to develop CRC unless early measures are taken and those with Lynch syndrome have a 50-80% chance of CRC development. If high-risk mutations are found, family members can take precautions, such as increased surveillance and behavioral modification.
A limitation of the study was a uniform means of genetic testing for all patients. The researchers hope to continue an examination of this CRC age group, focusing on the two-thirds of patients that lacked an identified genetic cause of their disease. The results of this study were published in the Journal of Clinical Oncology.
Approximately 5% of all colorectal cases are due to hereditary causes, such as familial adenomatous polyposis (FAP) or Lynch syndrome.
Sign Up for Free e-newsletters
- Fluorouracil Associated With Reduced Surgery for Squamous Cell Carcinoma
- Incidence of Post-traumatic Stress Disorder High Among Patients With Cancer
- Long-Term Night Shift Work Associated With Cancer Risk in Women
- Distress, Neuroticism Predict Long-term Emotional Distress After Cancer Diagnosis
- FDA Grants Breakthrough Therapy Designation to Lenvatinib Plus Pembrolizumab for RCC
- Bacteria in Probiotics Carry Potential Risks for Immunocompromised Patients
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Patient Satisfaction Ratings Can Be Negatively Impacted by Nurse Staffing Ratio
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- Comparison of Survival Outcomes Between Radical Hysterectomy and Definitive Radiochemotherapy in Stage IB1 and IIA1 Cervical Cancer
- Fosfomycin Effective Alternate for Febrile Neutropenia Prophylaxis
- Adherence to Skin Cancer Screening Guidelines Beneficial in Management SCC in SOTRs
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|